Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diazene JK-279: potential anticancer drug.

M Osmak1, T Bordukalo, B Jernej

  • 1Department of Molecular Genetics, Ruder Bosković Institute, Zagreb, Croatia. osmak@rudjer.irb.hr

Anti-Cancer Drugs
|December 10, 1999
PubMed
Summary

Newly synthesized diazenecarboxamides were tested for anticancer effects. Diazene JK-279 showed significant cytotoxicity against all 10 human cancer cell lines, including drug-resistant types, indicating its potential as an anticancer drug.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NMR Investigation of the Copper(II)-Ciprofloxacin System.

Metal-based drugs·2008
Same author

Total tissue lactate dehydrogenase activity in endometrial carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2008
Same author

Selective cytotoxicity of diazenecarboxamides towards human leukemic cell lines.

Toxicology in vitro : an international journal published in association with BIBRA·2007
Same author

Lithium increases expression of p21(WAF/Cip1) and survivin in human glioblastoma cells.

Cell biology and toxicology·2006
Same author

Structurally similar diazenes exhibit significantly different biological activity.

Cell biology and toxicology·2006
Same author

Diazene JK-279 induces apoptosis-like cell death in human cervical carcinoma cells.

Toxicology in vitro : an international journal published in association with BIBRA·2005

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Development of novel anticancer agents is crucial to overcome drug resistance.
  • Diazenecarboxamides represent a class of compounds with potential therapeutic applications.

Purpose of the Study:

  • To evaluate the cytotoxic effects of 10 novel diazenecarboxamides.
  • To assess the efficacy of these compounds against various human cancer cell lines, including drug-resistant variants.

Main Methods:

  • Synthesis of 10 novel diazenecarboxamide compounds.
  • Cytotoxicity assessment using a modified colorimetric MTT assay.
  • Testing on 10 human cancer cell lines: cervical, laryngeal, glioblastoma, breast, and mammary carcinoma, including parental and drug-resistant strains.

Related Experiment Videos

Main Results:

  • Diazene JK-279 demonstrated significant cytotoxicity against all 10 tested cell lines, including five drug-resistant ones.
  • Diazene JK-835 showed cytotoxic effects on nine out of 10 cell lines.
  • Limited cytotoxic activity was observed for diazenes LV-57, MG-19, JK-429, and JK-913 at high concentrations.

Conclusions:

  • Diazene JK-279 exhibits broad-spectrum cytotoxicity and is a promising candidate for further anticancer drug development.
  • The study highlights the potential of diazenecarboxamides in combating drug-resistant cancers.